Prostate Cancer: A Practical Approach to Current Management of Recurrent Disease

Walczak, Janet R.; Carducci, Michael A.
February 2007
Mayo Clinic Proceedings;Feb2007, Vol. 82 Issue 2, p243
Academic Journal
Prostate cancer is the leading cause of cancer in men in the United States, with 234,460 men expected to be diagnosed as having the disease-In 2006 (33% of cancers in men), and the third leading cause of cancer deaths in men, with 27,350 men expected to die of the disease (9% of cancer deaths). Through early detection and improved local therapies, including surgery or radiation therapy, a large number of men will be cured, but unfortunately, a significant number of men will still experience relapse of disease and require continued surveillance and ongoing therapy. This article discusses approaches to treatment of men who have recurrent disease, including active surveillance, androgen ablation therapy, secondary hormone therapy, chemotherapy, bisphosphonates, radiation therapy, and future directions.


Related Articles

  • Lycopene in treatment of high-grade gliomas: A pilot study. Puri, Tarun; Goyal, Shikha; Julka, Pramod K.; Nair, Omana; Sharma, Daya N.; Rath, Goura K. // Neurology India;Jan2010, Vol. 58 Issue 1, p20 

    Background: The therapeutic benefit of lycopene is well established for carcinoma prostate in various clinical trials and has been proposed for other malignancies including high-grade gliomas. Setting and Design: Randomized placebo control study in the Department of Radiation Oncology of a...

  • Aspirin for Treating Breast Cancer. Schor, Jacob // Townsend Letter;Aug/Sep2013, Issue 361/362, p76 

    The article discusses studies on the use of aspirin for breast cancer treatment. Peter Rothwell and colleagues reported in a 2012 issue of "Lancet" journal that aspirin managed to reduce cancer-related mortality by 15 percent. In separate issues of the "Journal of Clinical Oncology," Michelle...

  • Nerve Growth Factor in Cancer Cell Death and Survival. Molloy, Niamh H.; Read, Danielle E.; Gorman, Adrienne M. // Cancers;2011, Vol. 3 Issue 1, p510 

    One of the major challenges for cancer therapeutics is the resistance of many tumor cells to induction of cell death due to pro-survival signaling in the cancer cells. Here we review the growing literature which shows that neurotrophins contribute to pro-survival signaling in many different...

  • Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer. Guérin, O.; Formento, P.; Lo Nigro, C.; Hofman, P.; Fischel, J.; Etienne-Grimaldi, M. C.; Merlano, M.; Ferrero, J. M.; Milano, G. // Journal of Cancer Research & Clinical Oncology;Jan2008, Vol. 134 Issue 1, p51 

    Physiological and molecular findings indicate over-expression of HER proteins and dysregulation of neo-angiogenesis during progression of advanced prostate cancer. The aim of this study was to test a novel rational therapeutic approach by combining docetaxel with an EGFR-targeting agent...

  • Prostate cancer screening worthwhile in some.  // PharmacoEconomics & Outcomes News;6/29/2013, Issue 681, p10 

    The article discusses research being done on prostate cancer screening, which references a study by A. J. Martin et al. published in the January 2013 issue of the "Medical Journal of Australia."

  • The dynamics of colorectal cancer management in 17 countries. Kanavos, Panos; Schurer, Willemien // European Journal of Health Economics;2010 Supplement 1, Vol. 10, p115 

    This paper discusses the current care management arrangements for colorectal cancer (CRC) in 16 OECD countries plus the Russian Federation by analysing data sources, the uptake of screening and surveillance, the available capacity in endoscopy services, the treatment pathways in medical...

  • Mechanisms of Androgen-Refractory Prostate Cancer. Debes, Jose D.; Tindall, Donald J. // New England Journal of Medicine;10/7/2004, Vol. 351 Issue 15, p1488 

    Comments on a study in this issue which looks at treatments which may increase the survival of patients with androgen-refractory prostate cancer. Background on the disease and how historically once the cancer becomes refractory to androgen ablation treatment, options have been only palliative;...

  • Prostate News.  // Prostate Cancer & Prostatic Diseases;2007, Vol. 10 Issue 3, p212 

    This article presents new briefs pertaining to prostate cancer. Dr. Devanand Sarkar and his associates did an examination to determine how an engineered conditionally replication-competent adenovirus could affect prostate cancer cells. A toxin that is activated by a prostate-specific antigen was...

  • A Comprehensive Review on Breast Cancer. Patidar, Arjun; Shivhare, S. C.; Ateneriya, Umesh; Choudhary, Sonu // Indian Journal of Public Health Research & Development;Jul-Sep2013, Vol. 4 Issue 3, p291 

    The incidence of Breast Cancer is increasing, particularly in previously low incidence area such as Asian developing country like India. In the Present article Authors tried to review the Breast cancer statistics with the help of Graphical data. The comprehensive study also review with special...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics